RNAZ TRANSCODE THERAPEUTICS INC Investments/Divestments 8-K Filing 2024 - Securities Purchase Agreement Transcode Therapeutics, Inc. entered into a Securities Purchase Agreement to sell 5,942,623 shares of common stock in a public offering, raising approximately $7.25 million.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC